Hyderabad's PopVax develops AI-designed personalized mRNA cancer vaccines, targets 100+ doses in 12 months
The Indian startup says it uses AI to design individualized mRNA cancer vaccines and plans manufacturing scale-up, part of a broader push into personalized onco
Startup Pedia · +4 outlets
FDA advances plug-and-play gene therapy framework years in the making
The agency is moving to standardize gene therapy platforms so developers can swap in new payloads without redoing the full regulatory process.
BioSpace · +11 outlets
FDA proposes withdrawing Tavneos approval in the US
The proposal would pull an approved drug from the US market, a rare regulatory step with implications for its developer and patients.
UA.NEWS · +10 outlets
Gene editing shares jump on ESGCT data and new FDA draft guidance
Clinical data presented at ESGCT along with an FDA draft guidance lifted shares across gene editing developers.
Genetic Engineering and Biotechnology Ne · +1 outlets
FDA approves breakthrough drug for advanced pancreatic cancer
The approval adds a new treatment option for a cancer with historically poor outcomes.
University of Colorado Anschutz · +13 outlets
FDA advisers narrowly vote to add six peptides to the drug compounding list
The close vote sets up a decision on whether compounded versions of the peptides can be legally prepared.
The American Journal of Managed Care® (A · +6 outlets
Citi questions whether melanoma mRNA vaccine benefit justifies individualized tumor harvesting and manufacturing
The analyst note flags the operational complexity of producing a personalized vaccine per patient as a hurdle to commercial adoption.
Stocktwits · +2 outlets
Scientists identify how common gut bacterium triggers colon cancer and a way to block its toxin
Johns Hopkins researchers report claudin-4 as the receptor for Bacteroides fragilis toxin, pointing to a possible target for blocking colorectal cancer promotio
ABP Live English · +4 outlets
Merck cancer strategy turns personalized as stock rises
Merck's move toward individualized cancer approaches drew investor attention amid broader earnings-season focus on oncology bets.
TheStreet · +14 outlets
Moderna, BioNTech melanoma mRNA vaccine coverage focuses on first personalized cancer shot
Explanatory coverage describes how the first mRNA cancer vaccine works and its potential to reshape melanoma treatment.
Evidence Network · +10 outlets
BridgeBio prepares rare muscular dystrophy launch with FDA approval in sight
The company is building commercial infrastructure ahead of a potential FDA decision in a rare neuromuscular disease.
BioSpace · +1 outlets
Pretzel Therapeutics wins UK approval to advance PX578 into Phase II for rare mitochondrial disease
The UK clearance moves the mitochondrial disease candidate into mid-stage testing.
BioPharma APAC
India's medicine sales grow in double digits for four straight quarters on chronic care drugs
Chronic disease therapies are driving sustained growth in the Indian pharmaceutical market.
The Economic Times · +11 outlets
BioNTech founders receive science award
The award recognizes the founders' work on mRNA technology that underpins their cancer vaccine programs.
Hürriyet Daily News · +3 outlets
Percheron Therapeutics gains FDA clearance for cancer trial
The clearance allows the company to start a US clinical study in oncology.
grafa.com · +2 outlets
Midterms seen reshaping US health policy on several fronts
Policymakers, lobbyists and experts outline the potential healthcare policy shifts regardless of election outcomes.
STAT · +3 outlets
Scientists use sound waves to deliver new attack on deadly brain cancer
The approach uses focused ultrasound to reach tumors that are otherwise hard to treat.
Science Daily · +1 outlets
Biotech outperforms broader market as Novo, Pfizer and Moderna earnings approach
The sector's relative strength comes ahead of a heavy week of large-cap pharma results.
Yahoo Finance